ACHELIOS THERAPEUTICS

Profile

Company Names

ACHELIOS THERAPEUTICS
ACHELIOS THERAPEUTICS, INC.

Addresses

6340 QUADRANGLE DRIVE, SUITE 120, CHAPEL HILL, NC 27517

1340 ENVIRON WAY, CHAPEL HILL, NC 27517

Phone Numbers

919-913-4605

 

Entity Type:

LIMITED LIABILITY COMPANY

Industry:

OTHER HEALTH CARE, PHARMACEUTICALS

Year Incorporated:

2012

State Incorporated:

DELAWARE

Total Amount Raised:

$3,520,442.00

Number of Funding Rounds:

2
Investment Rounds
Round #
Round Open Date
Amount Raised
Total Round Size
Amount Remaining to be Raised
Securities
2
2016-04-07 
$350,000.00 
$2,000,000.00 
$1,650,000.00 
Debt 
1
2012-02-03 
$3,170,442.00 
$4,250,000.00 
$1,079,558.00 
Equity 
People
First Name
Middle Name
Last Name
Titles
Related Companies
WILLIAM 
 
BAUER 
DIRECTOR
ACHELIOS THERAPEUTICS, INC.
WILLIAM 
 
DICKIE 
DIRECTOR
EXODOS LIFE SCIENCES LIMITED PARTNERSHIP   |  ACHELIOS THERAPEUTICS, INC.   |  ADVANCED PROTEOME THERAPEUTICS INC.
CRIST 
 
FRANGAKIS 
EXECUTIVE OFFICER
EXODOS LIFE SCIENCES LIMITED PARTNERSHIP   |  ACHELIOS THERAPEUTICS
CRIST 
J. 
FRANGAKIS 
EXECUTIVE OFFICER, DIRECTOR
EXODOS LIFE SCIENCES LIMITED PARTNERSHIP   |  ACHELIOS THERAPEUTICS, INC.
JERRY 
 
ROSENBLATT 
DIRECTOR
EXODOS LIFE SCIENCES LIMITED PARTNERSHIP   |  ACHELIOS THERAPEUTICS, INC.
RON 
 
VERED 
DIRECTOR
JENNEREX, INC.   |  CERTIRX CORP   |  EXODOS LIFE SCIENCES LIMITED PARTNERSHIP   |  ACHELIOS THERAPEUTICS, INC.
Filings
Filing Date
Filing Type
Source URL
Industry Classifier
Detailed Industry
Revenue Range
Securities
First Sale Date
2016-04-19
D
Link
OTHER HEALTH CARE 
 
DECLINE TO DISCLOSE 
Debt 
2016-04-07 
2014-03-13
D/A
Link
PHARMACEUTICALS 
 
DECLINE TO DISCLOSE 
Equity 
2012-02-03 
2012-02-21
D
Link
PHARMACEUTICALS 
 
DECLINE TO DISCLOSE 
Equity 
2012-02-03 
Brokers
Broker Dealer
Broker CRD#
Recipient Name
Recipient CRD#